Nivalon Medical Technologies Inc. — SEC Form D Filing

Nivalon Medical Technologies Inc. filed an SEC Form D on April 21, 2026, reporting $150K raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
April 21, 2026
Amount reported
$150K
Round stage
Seed
Industry
Healthcare Technology
Website
https://www.nivalonmedical.com/

What the company does

Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Healthcare providers struggle with inefficient patient monitoring and data management.

Solution

Nivalon Medical Technologies provides advanced solutions for real-time patient monitoring and streamlined data management.

Verdict

Investors said yes because they saw a pressing need for innovative patient monitoring solutions in healthcare, not because the market lacked alternative offerings. They were implicitly betting on Nivalon’s ability to penetrate a healthcare sector struggling with inefficiencies despite significant existing competition. However, the upside is limited by the presence of established players in the health tech space, which could restrict Nivalon’s market capture and durability.

Source: SEC EDGAR Form D filing